Effects of galcanezumab on acute medication use and health care resource utilization in treatment-resistant migraine: results from randomized, double blind, placebo-controlled clinical trial, conquer. Headache Med [Internet]. 2020 Nov. 30 [cited 2026 Jan. 22];11(Supplement):27. Available from: https://headachemedicine.com.br/hm/article/view/112